Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Constipation (Methylnaltrexone bromide - Constipation)

Records returned : 24 (on 29 May 2025 at 12:53:37). Return to search results for ' Constipation '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

Drug:

Indication :

Constipation

Status :

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

Drug:

Indication :

Constipation

Status :

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

3. Methylnaltrexone bromide

Drug:

Methylnaltrexone bromide

Indication :

Constipation

Status :

Red

Formulations :

Injection

Restrictions / Comments:

Important

For opioid-induced constipation in terminally ill patients when response to other laxatives is inadequate

RSCH Palliative Care Team only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

4. Arachis oil

Drug:

Arachis oil

Indication :

Constipation

Status :

Green

Formulations :

Enema

Restrictions / Comments:

Important

Allergy warning - contains peanut oil

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

5. Bisacodyl

Drug:

Bisacodyl

Indication :

Constipation

Status :

Green

Formulations :

Suppositories
Tablets

Restrictions / Comments:

Important

NOTE - 7.5mg suppositories are non-formulary. Only the licensed 5mg and 10mg suppositories should be prescribed

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

24. Bisacodyl

Drug:

Bisacodyl

Indication :

Constipation

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Important

7.5mg suppositories are unlicensed and not approved for use in Surrey Heartlands.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

6. Docusate sodium

Drug:

Docusate sodium

Indication :

Constipation

Status :

Green

Formulations :

Capsules
Oral solution

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

7. Docusate sodium

Drug:

Docusate sodium

Indication :

Constipation

Status :

Green

Formulations :

Enema

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

8. Glycerol

Drug:

Glycerol

Indication :

Constipation

Status :

Green

Formulations :

Suppositories

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

9. Ispaghula husk

Drug:

Ispaghula husk

Indication :

Constipation

Status :

Green

Formulations :

Sachets (granules)

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

10. Lactulose

Drug:

Lactulose

Indication :

Constipation

Status :

Green

Formulations :

Oral solution

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

11. Macrogol compound

Drug:

Macrogol compound

Indication :

Constipation

Status :

Green

Formulations :

Sachets (powder)

Restrictions / Comments:

Important

Prescribe as macrogol compound oral powder sachets. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

21. Macrogol compound

Drug:

Macrogol compound

Indication :

Constipation

Status :

Red

Formulations :

Sachets (powder)

Restrictions / Comments:

Important

Moviprep / Plenvu - ADULTS only. Off-label use. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

12. Magnesium hydroxide

Drug:

Magnesium hydroxide

Indication :

Constipation

Status :

Green

Formulations :

Oral suspension

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

13. Naldemedine

Drug:

Naldemedine

Indication :

Constipation

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Opioid-induced constipation. Only after other laxatives have been unsuccessful.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

14. Phosphates (Rectal)

Drug:

Phosphates (Rectal)

Indication :

Constipation

Status :

Green

Formulations :

Enema

Restrictions / Comments:

Important

Contraindicated in patients with CKD, dehydration and heart failure (among others).

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

15. Prucalopride

Drug:

Prucalopride

Indication :

Constipation

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Only after a trial of at least 2 other classes of laxative at the highest recommended, tolerated doses. Consider stopping after 4 weeks if not effective.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :